PROGRESS OF DEVELOPMENT
Disclosuring of information after Phase 1
Drug | Indication | Status (Region) |
---|---|---|
Difluprednate | inflammation associated with ocular surgery, Uveitis | Approved (Russia) |
Pranoprofen | inflammation | Application under review (Vietnam) |
SJP-0132 | Dry eye | P3(Japan) |
SJP-0135 | Glaucoma | P3(Japan) |
SJP-0008 | Central Retinal Artery Occlusion (CRAO) | P3(Japan) |
SJP-0170 | Glaucoma | P3(Japan) |
SJP-0154 | Dry eye | P2(Japan) |